{"id":12042,"date":"2020-07-03T15:38:53","date_gmt":"2020-07-03T13:38:53","guid":{"rendered":"https:\/\/www.mannheimerswartling.se\/?p=12042"},"modified":"2025-01-15T13:30:00","modified_gmt":"2025-01-15T12:30:00","slug":"camurus-ab-has-completed-a-directed-issue-of-sek-300-million","status":"publish","type":"post","link":"https:\/\/www.mannheimerswartling.se\/en\/assignment\/camurus-ab-has-completed-a-directed-issue-of-sek-300-million\/","title":{"rendered":"Camurus AB has completed a directed issue of SEK 300 million"},"content":{"rendered":"<p>Camurus has completed a directed issue to Swedish and international institutional investors raising SEK 300 million through an accelerated book building process.<\/p>\n<p>Camurus is a Swedish research-based biopharmaceutical company committed to developing and commercialising innovative and differentiated medicines for the treatment of severe and chronic conditions. New drug products with best-in-class potential are conceived based on proprietary FluidCrystal\u00ae drug delivery technologies and an extensive R&amp;D expertise. Camurus&#8217; clinical pipeline includes products for the treatment of cancer, endocrine diseases, pain and addiction. Camurus&#8217; shares are listed on Nasdaq Stockholm.<\/p>\n<p>Camurus was advised by Mannheimer Swartling in the transaction.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Camurus has completed a directed issue to Swedish and international institutional investors raising SEK 300 million through an accelerated book building process. Camurus is a\u2026<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[4313],"tags":[],"class_list":["post-12042","post","type-post","status-publish","format-standard","hentry","category-assignment","business-group-public-ma-and-equity-capital-markets"],"acf":[],"lang":"en","translations":{"en":12042,"sv":12040},"pll_sync_post":[],"_links":{"self":[{"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/posts\/12042"}],"collection":[{"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/comments?post=12042"}],"version-history":[{"count":3,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/posts\/12042\/revisions"}],"predecessor-version":[{"id":29463,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/posts\/12042\/revisions\/29463"}],"wp:attachment":[{"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/media?parent=12042"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/categories?post=12042"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.mannheimerswartling.se\/wp-json\/wp\/v2\/tags?post=12042"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}